全文获取类型
收费全文 | 6330篇 |
免费 | 495篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 53篇 |
儿科学 | 206篇 |
妇产科学 | 142篇 |
基础医学 | 968篇 |
口腔科学 | 96篇 |
临床医学 | 681篇 |
内科学 | 1209篇 |
皮肤病学 | 164篇 |
神经病学 | 703篇 |
特种医学 | 161篇 |
外科学 | 619篇 |
综合类 | 51篇 |
一般理论 | 11篇 |
预防医学 | 633篇 |
眼科学 | 114篇 |
药学 | 412篇 |
中国医学 | 9篇 |
肿瘤学 | 612篇 |
出版年
2023年 | 94篇 |
2022年 | 70篇 |
2021年 | 252篇 |
2020年 | 209篇 |
2019年 | 269篇 |
2018年 | 264篇 |
2017年 | 222篇 |
2016年 | 240篇 |
2015年 | 232篇 |
2014年 | 310篇 |
2013年 | 390篇 |
2012年 | 591篇 |
2011年 | 548篇 |
2010年 | 274篇 |
2009年 | 281篇 |
2008年 | 420篇 |
2007年 | 406篇 |
2006年 | 362篇 |
2005年 | 336篇 |
2004年 | 285篇 |
2003年 | 249篇 |
2002年 | 224篇 |
2001年 | 29篇 |
2000年 | 17篇 |
1999年 | 15篇 |
1998年 | 24篇 |
1997年 | 14篇 |
1996年 | 12篇 |
1995年 | 15篇 |
1994年 | 17篇 |
1993年 | 18篇 |
1992年 | 10篇 |
1991年 | 6篇 |
1990年 | 6篇 |
1989年 | 3篇 |
1988年 | 10篇 |
1987年 | 5篇 |
1986年 | 6篇 |
1985年 | 9篇 |
1984年 | 4篇 |
1983年 | 6篇 |
1982年 | 9篇 |
1981年 | 11篇 |
1980年 | 9篇 |
1979年 | 4篇 |
1977年 | 3篇 |
1969年 | 6篇 |
1958年 | 3篇 |
1954年 | 3篇 |
1926年 | 3篇 |
排序方式: 共有6844条查询结果,搜索用时 31 毫秒
1.
2.
Collagens are the most abundant proteins in the extracellular matrix. They provide a framework to build organs and tissues and give structural support to make them resistant to mechanical load and forces. Several intra‐ and extracellular modifications are needed to make functional collagen molecules, intracellular post‐translational modifications of proline and lysine residues having key roles in this. In this article, we provide a review on the enzymes responsible for the proline and lysine modifications, that is collagen prolyl 4‐hydroxylases, 3‐hydroxylases and lysyl hydroxylases, and discuss their biological functions and involvement in diseases. 相似文献
3.
Monica Poiani Myriam Labopin Giorgia Battipaglia Dietrich W. Beelen Johanna Tischer Jürgen Finke Arne Brecht Edouard Forcade Arnold Ganser Jakob R. Passweg Helene Labussiere‐Wallet Ibrahim Yakoub‐Agha Kerstin Schfer‐Eckart Nicolaus Kroeger Blandine Guffroy Annalisa Ruggeri Jordi Esteve Arnon Nagler Mohamad Mohty 《American journal of hematology》2021,96(1):40-50
Karyotypic analysis at time of diagnosis has an important value in determining initial response to treatment, remission duration and overall survival (OS) in acute myeloid leukemia (AML). Less is known about its value before allogeneic hematopoietic cell transplantation (allo‐HCT) in patients transplanted with active disease, either relapsed or primary refractory (Rel‐Ref) AML. We explored the impact of cytogenetic risk (stratification according to MRC‐UK) in 2089 patients with either Ref (n = 972) or Rel AML (n = 1117) transplanted during the period 2000‐2017. Overall, 154 patients had a favorable risk, 1283 had an intermediate risk and 652 had an adverse cytogenetic risk. Median follow‐up was 49 months. Compared to the favorable risk group, intermediate and adverse risk patients were associated with worse leukemia‐free survival and OS and also with a higher incidence of relapse. In a subgroup analysis of patients in the intermediate risk group harboring Fms‐like tyrosine kinase 3‐internal tandem duplication (FLT3‐ITD), this remained an important prognostic factor, being associated with worse outcomes. When analyzing patients according to the intensity of the conditioning regimen, no differences were observed for the main transplant outcomes. In conclusion, in patients diagnosed with AML and transplanted with active disease, karyotype remains an important prognostic factor, allowing splitting patients into different risk groups according to their cytogenetics. Similarly, FLT3‐ITD mutation also remains a negative prognostic factor in this population. 相似文献
4.
5.
6.
7.
Neil Ryan Johanna Wall Emma J Crosbie Mark Arends Tjalling Bosse Saimah Arif Asma Faruqi Ian Frayling Raji Ganesan Ye L Hock Raymond McMahon Ranjit Manchanda W Glenn McCluggage Pinias Mukonoweshuro Gerhard van Schalkwyk Lucy Side John H Smith Bruce Tanchel D Gareth Evans C Blake Gilks Naveena Singh 《Histopathology》2019,75(6):813-824
8.
9.